Descongestionantes nasais e o risco de eventos cardiovasculares: uma revisão da literatura

Abstract

Chronic Respiratory Diseases are diseases that affect both the upper and lower respiratory tract and represent one of the biggest health problems worldwide, with allergic rhinitis being the most prevalent rhinopathy, affecting approximately 17 million people in Brazil. Such diseases directly affect the patient's quality of life, since in addition to impairing the performance of professional, school, and social activities, they also interfere with sleep quality. The present study aimed to identify in the scientific literature publications referring to the manifestation of cardiovascular events associated with the use of nasal decongestants. A literature review was carried out in the PUBMED database, with the following keywords: “nasal decongestants AND stroke” and “nasal decongestants AND myocardial infarction” Fifteen studies were included and analyzed, in which the occurrence of stroke or myocardial infarction associated with the use of nasal vasoconstrictors was reported. Such cardiovascular events were observed in patients, regardless of age and dose administered. The studies present quality scientific evidence, emphasizing the need for greater population knowledge of these effects.